Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Enveric Biosciences Inc (NQ: ENVB ) 0.4710 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jul 25, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Enveric Biosciences Inc < Previous 1 2 3 4 5 6 7 8 9 ... 12 13 Next > Psychedelics Headlines: Substitution Survey, Frank Herbert's Magic Mushrooms, Celestial Plans And News Review March 16, 2024 Via Benzinga Enveric Biosciences Announces New Patent Issuances Protecting Multiple Assets Covered by Non-Binding Term Sheets March 12, 2024 From Enveric Biosciences Via Business Wire Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More March 04, 2024 Via Benzinga S&P 500 Moves Higher; Hayward Holdings Shares Jump On Upbeat Results February 29, 2024 U.S. stocks traded mixed toward the end of trading, with the S&P 500 gaining around 0.3% on Thursday. The Dow traded down 0.08% to 38,919.26 while the NASDAQ rose 0.53% to 16,032.35. The S&P 500 also... Via Benzinga Topics Stocks Exposures US Equities Why Is Enveric Biosciences (ENVB) Stock Up 120% Today? February 29, 2024 Investors in Enveric Biosciences are seeing massive gains today, as ENVB stock more than doubles on a huge uptick in trading volume. Via InvestorPlace Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session February 29, 2024 Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results. Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session February 29, 2024 Via Benzinga Crude Oil Moves Higher; Best Buy Posts Upbeat Earnings February 29, 2024 U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining around 100 points on Thursday. The Dow traded down 0.16% to 38,884.96 while the NASDAQ rose 0.38% to 16,008.19. The... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why Enveric Biosciences Stock Is Soaring February 29, 2024 Enveric said it could be eligible to receive future development and sales milestone payments and execution fees for the three licenses, which in total could add up to $200 million, assuming certain... Via Benzinga Nasdaq Gains 100 Points Following PCE Data February 29, 2024 U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 100 points on Thursday. Following the market opening Thursday, the Dow traded down 0.07% to 38,923.11 while the... Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Thursday's Pre-Market Session February 29, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday February 29, 2024 It's time to dive into the biggest pre-market stock movers for Thursday as we check out all of the news affecting shares this morning! Via InvestorPlace Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of Three Classes of Compounds February 29, 2024 From Enveric Biosciences Via Business Wire EXCLUSIVE: Enveric Biosciences Announces Non-Binding Deals To License Out Three Types of Drug Compounds February 29, 2024 Via Benzinga Medical Breakthrough Stocks Under $1: OCGN, VERO, RSCI, VTAK, ENVB February 28, 2024 Via AB Newswire Topics Intellectual Property Exposures Intellectual Property Enveric Biosciences Sells Cancer Patents As It Paves Way For Mental Health Treatments February 23, 2024 Enveric Biosciences Inc. has announced the sale of a cancer-related patent portfolio, including patents and pending applications in several countries, focusing on cannabidiol as a treatment for cancer.... Via Benzinga Topics Intellectual Property Exposures Intellectual Property 12 Health Care Stocks Moving In Friday's Intraday Session February 23, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session February 23, 2024 Via Benzinga Enveric Biosciences Agrees to Sell Cancer-Targeting Cannabinoid-Related Intellectual Property February 23, 2024 From Enveric Biosciences Via Business Wire Enveric Biosciences Deepens Its Mental Health-Focused Pipeline With Library of Preclinical Compounds February 21, 2024 Enveric Biosciences announced discovery of multiple compounds using its Psybrary platform and AI system. These compounds broaden their range of mental health treatments. Via Benzinga Topics Artificial Intelligence Exposures Artificial Intelligence Enveric Biosciences Unveils Library of Preclinical Compounds Across Multiple Distinct Molecule Classes Targeting Mental Health Disorders February 21, 2024 From Enveric Biosciences Via Business Wire Psyched: Psychedelics & Sex, MDMA And Federal Approval, Canadians For End-Of-Life Care And More February 15, 2024 Via Benzinga Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More January 27, 2024 New study finds suggestibility plays a role in antidepressant effects of psilocybin therapy. EU invests 6.5M euros in psychedelics for pulmonary disorder, MS, ALS, and Parkinson's. Australian... Via Benzinga Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More January 12, 2024 Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD Via Benzinga 30 Psychedelics Executives, Scientists & Influencers To Watch In 2024 And Beyond January 10, 2024 The emerging psychedelics industry is expanding rapidly across the globe. With research demonstrating promising therapeutic potential for substances like psilocybin and MDMA to treat mental health... Via Benzinga Psyched: Ibogaine For TBI, Kentucky Initiative Stalled, DEA Quotas, Insurance Codes, Atai's $50M And More January 07, 2024 Ibogaine Therapy Shows Promising Outcomes For Veterans With Trauma Brain Injury Via Benzinga Enveric Biosciences Updates Key Data Underpinning Selection of EB-003 as Lead Drug Candidate from EVM301 Series January 03, 2024 From Enveric Biosciences Via Business Wire 12 Health Care Stocks Moving In Monday's Pre-Market Session January 01, 2024 Via Benzinga Why Fisker Shares Are Trading Higher By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session December 29, 2023 Shares of Fisker Inc. (NYSE: FSR) rose sharply during Friday’s session after the company provided a December 2023 business update. Via Benzinga Enveric Biosciences Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $1.8 Million Gross Proceeds Priced At-the-Market December 29, 2023 From Enveric Biosciences Via Business Wire < Previous 1 2 3 4 5 6 7 8 9 ... 12 13 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.